BN Business News
Добавете компания →

Фирмени съобщения · 13.11.2026 г.1 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Локален автоматичен превод · Оригинален език на източника

EDITORIAL ILLUSTRATIONФСФирмени съобщенияBN
Illustration generated by Business News; it is not a source photograph.

Summary

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Оригинален език на източника: PR Newswire UK — News ReleasesОтворете оригиналното съобщение →

Explore insights

Business insights →